Goldman JM - Search Results

1

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.

Gao L, Bellantuono I, Elsässer A, Marley SB, Gordon MY, Goldman JM, Stauss HJ. Gao L, et al. Among authors: goldman jm. Blood. 2000 Apr 1;95(7):2198-203. Blood. 2000. PMID: 10733485 Free article.

2

CD34+ cell selection in chronic phase chronic myeloid leukaemia: a comparison of laboratory grade columns.

Hawkins TE, Marley SB, O'Brien SG, Gordon MY, Goldman JM. Hawkins TE, et al. Among authors: goldman jm. Bone Marrow Transplant. 1997 Sep;20(5):409-13. doi: 10.1038/sj.bmt.1700908. Bone Marrow Transplant. 1997. PMID: 9339758

3

The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.

Dazzi F, Capelli D, Hasserjian R, Cotter F, Corbo M, Poletti A, Chinswangwatanakul W, Goldman JM, Gordon MY. Dazzi F, et al. Among authors: goldman jm. Blood. 1998 Aug 15;92(4):1390-6. Blood. 1998. PMID: 9694728 Free article.

4

Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

Gordon MY, Marley SB, Lewis JL, Davidson RJ, Nguyen DX, Grand FH, Amos TA, Goldman JM. Gordon MY, et al. Among authors: goldman jm. J Clin Invest. 1998 Aug 15;102(4):710-5. doi: 10.1172/JCI3094. J Clin Invest. 1998. PMID: 9710439 Free PMC article.

5

Cell biology of CML cells.

Gordon MY, Dazzi F, Marley SB, Lewis JL, Nguyen D, Grand FH, Davidson RJ, Goldman JM. Gordon MY, et al. Among authors: goldman jm. Leukemia. 1999 Apr;13 Suppl 1:S65-71. doi: 10.1038/sj.leu.2401281. Leukemia. 1999. PMID: 10232368 Review.

6

The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.

Marley SB, Deininger MW, Davidson RJ, Goldman JM, Gordon MY. Marley SB, et al. Among authors: goldman jm. Exp Hematol. 2000 May;28(5):551-7. doi: 10.1016/s0301-472x(00)00142-9. Exp Hematol. 2000. PMID: 10812245 Free article.

7

Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.

Marley SB, Davidson RJ, Goldman JM, Gordon MY. Marley SB, et al. Among authors: goldman jm. Leukemia. 2000 Aug;14(8):1396-400. doi: 10.1038/sj.leu.2401860. Leukemia. 2000. PMID: 10942234

8

The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells.

Lewis JL, Chinswangwatanakul W, Zheng B, Marley SB, Nguyen DX, Cross NC, Banerji L, Glassford J, Thomas NS, Goldman JM, Lam EW, Gordon MY. Lewis JL, et al. Among authors: goldman jm. Blood. 2001 May 1;97(9):2604-10. doi: 10.1182/blood.v97.9.2604. Blood. 2001. PMID: 11313248 Free article.

9

Progenitor cells from patients with advanced phase chronic myeloid leukaemia respond to STI571 in vitro and in vivo.

Marley SB, Davidson RJ, Lewis JL, Nguyen DX, Eades A, Parker S, Goldman JM, Gordon MY. Marley SB, et al. Among authors: goldman jm. Leuk Res. 2001 Nov;25(11):997-1002. doi: 10.1016/s0145-2126(01)00066-2. Leuk Res. 2001. PMID: 11597734

10

Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen, CD34.

Gordon MY, Marley SB, Davidson RJ, Grand FH, Lewis JL, Nguyen DX, Lloyd S, Goldman JM. Gordon MY, et al. Among authors: goldman jm. Hematol J. 2000;1(2):77-86. doi: 10.1038/sj.thj.6200017. Hematol J. 2000. PMID: 11920174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

905 results

Search Page

Filters